Happiest Health Hosts Second Edition of ‘Happiest Her' Summit in Bengaluru
Bengaluru: Health and wellness platform Happiest Health successfully concluded the second edition of its flagship women's wellness summit, Happiest Her 2025, on Saturday at Pope Paul VI Auditorium, St. John's Campus, Bengaluru. The event brought together over 250 participants, including healthcare professionals, fitness experts, and mental health advocates, to spotlight the health and well-being of working women in India.
The summit was inaugurated by Davis Karedan, Co-Chairman of Happiest Health, alongside NIMHANS Director Dr. Pratima Murthy, and Co-CEOs Raghu Krishnan and Ravi Joshi. Dr. Murthy, in her keynote address on "Empowering Young Working Women", stressed the role of lifestyle choices in shaping long-term health. "Genes load the gun, lifestyle pulls the trigger," she remarked, underlining the importance of exercise and balanced nutrition in preventing chronic diseases.
A panel on Metabolism and Poor Lifestyle Choices featured leading voices in women's health, including gynaecologist Dr. Vidya V Bhat, psychologist Dr. Paras Sharma, and athlete-entrepreneur Saraswathi Anand. Anand spoke of her journey from a busy professional and mother to an international powerlifting champion, urging women to find time for fitness despite packed schedules.
Nutritionist Ryan Fernando, founder of Qua Nutrition, conducted a high-energy session on common diet mistakes, advising women to focus on building muscle. 'Muscle is the hero in your body,' he said, calling for a systematic investment in strength training for lifelong health.
The summit, through its expert-led discussions, highlighted challenges such as PCOS, stress, and metabolic disorders, while offering practical pathways to better health. As part of its ongoing efforts, Happiest Health announced that its current magazine issue focuses on strength training, and its diagnostics wing is now offering a gut microbiome test across India.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
6 hours ago
- New Indian Express
NIMHANS Northern campus in Bengaluru gets Centre's nod
BENGALURU: The Union Government has granted in-principle approval for the construction of a 300-bed Post-Graduate Polytrauma Centre under the National Institute of Mental Health and Neurosciences (NIMHANS) at Kyalasanahalli near Kempegowda International Airport (KIA), Bengaluru. The facility, estimated to cost Rs 498 crore, is aimed at providing advanced emergency and trauma care to accident victims in and around the Bengaluru region. The approval was issued by the Department of Expenditure under the Union Ministry of Finance, following a proposal submitted by the Ministry of Health and Family Welfare (MoHFW). The land for the project, measuring 39 acres, had been allotted to NIMHANS in 2012-13, during the tenure of the BJP-led state government in Karnataka. The proposed facility will serve as NIMHANS' Northern Campus and will include not just the trauma hospital, but also residential quarters for staff, hostels, guest houses, administrative blocks, and other support infrastructure. The Finance Ministry has laid down several conditions for the project. These include optimising manpower and infrastructure as recommended by NITI Aayog in its 2021 report, ensuring the trauma centre also caters to regular patients, and monitoring outputs and outcomes regularly for mid-course corrections. The ministry has also asked the Health Ministry to frame a long-term national policy for emergency and serious injury care. The Centre will provide critical care for patients suffering from multiple and complex injuries, particularly head, brain, chest, abdomen, and skeletal trauma, during the crucial 'Golden Hour.'
The Hindu
21 hours ago
- The Hindu
Centre approves 300-bed polytrauma centre at NIMHANS north campus in Bengaluru
The Central government has approved the establishment of a 300-bed Polytrauma Centre and Postgraduate Institute at Kyalasanahalli in Bengaluru North, where the north campus of NIMHANS is coming up. The project to be taken up at a cost of ₹498 crore was awaiting approval for the last 11 years. In July last year, C.N. Manjunath, Bengaluru Rural MP, had submitted a concept note on the proposal for the 300-bed polytrauma centre to the Union Health Minister J.P. Nadda, urging him to accord sanction at the earliest. According to the sanction letter dated June 27 by the Union Ministry of Finance, the Union Health Ministry should ensure optimisation of resources (manpower, infrastructure, supplies and medicines) as suggested by NITI Aayog in 2021, in its report titled 'Emergency and Injury Care at Secondary and Tertiary level Centres in India'. 'To optimise the resources of the polytrauma centre, the proposed facility should also cater to regular patients along with emergency cases,' the letter stated. Golden hour requirement 'Given that nearly 15% of deaths in India are due to road accidents and about 30% of accident victims suffer from multiple injuries, the need for a dedicated trauma facility is urgent. The ability to provide comprehensive, immediate care under one roof during the 'Golden Hour' can significantly improve survival rates and recovery outcomes,' he said. Pointing out that the polytrauma centre will serve as a crucial facility for the treatment of patients suffering from multiple and complex injuries, including those involving the head, brain, chest, abdomen and bones, the doctor-turned-politician said the Centre will play a vital role in addressing the growing shortage of hospital beds in Karnataka, especially in Bengaluru, and will ensure faster, more efficient trauma care. Importantly, it will also include a postgraduate institute to train trauma care specialists. NIMHANS overcrowded 'The outpatient footfall at NIMHANS, the country's premier mental health institution, has increased from around 250 patients a day to 2,500 a day now. The hospital is always overcrowded and not able to cope with the load of patients. Because of space constraints and the non-availability of polytrauma services, critical patients are shifted from NIMHANS to other hospitals. Some of them die during transit,' he said. 'This will be the second polytrauma centre in India, after the Jayaprakash Narayan Apex Trauma Centre at AIIMS, New Delhi, marking a significant expansion of India's trauma care infrastructure. Construction is set to be completed in 30 months,' Dr. Manjunath said. Although the State government had allotted 37 acres of land, and the above proposal has been approved by the governing body of the institution with many revisions and re-revisions, it was pending for almost 11 years, he said.
New Indian Express
6 days ago
- New Indian Express
Advanced treatment for Parkinson's offers better quality of life
When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle weakness, assuming that could be a sign of aging. A retired electrical engineer from Bengaluru, he experienced other symptoms after a few months and the tremors worsened. A few tests later, Nair was diagnosed with Parkinson's disease (PD), a progressive neurological disorder that affects movement apart from cognitive and emotional function. Though initially he managed it with medication, the relief was temporary. However, everything changed for the better early this year, after he underwent magnetic resonance-guided focused ultrasound (MRgFUS), a cutting edge procedure. Within days of the non-invasive treatment, the tremors that had dominated his life for years were nearly gone. Nair's case is one of many that demonstrate how advanced procedures are offering renewed hope to millions of Parkinson's patients. Despite the challenges, evolving technologies like focused ultrasound and deep brain stimulation are transforming management strategies and improving quality of life. Once mostly associated with older adults, PD is now alarmingly affecting younger populations in India, which now reports between 15 and 43 PD cases per one lakh people. Data from the National Institute of Mental Health and Neurosciences (NIMHANS) reveals that nearly 40-45% of Indian patients aged between 22-49 years experience the symptoms, which is nearly 10 years earlier than the global average. A recent study published in the British Medical Journal projects that the global Parkinson's population will reach 25.2 million by 2050, up by over 112% from 2021. South Asia, particularly India, is expected to account for nearly 6.8 million of these cases. The prevalence has been estimated at 267 cases per one lakh people worldwide. Invisible onset PD is the world's second most prevalent neurodegenerative disorder after Alzheimer's. The World Health Organization warns that neurodegenerative diseases, including Parkinson's and Alzheimer's, could surpass cancer as the second leading cause of death globally by 2040. The disease results from the gradual loss of dopamine-producing neurons in the brain. Dopamine is a chemical messenger essential for smooth and coordinated muscle movements. When dopamine levels drop, motor functions become impaired, leading to a range of uncontrollable symptoms. Parkinson's typically strikes people over 60, though younger cases (below 50) are also reported. Men are more likely to develop the condition than women. Some key symptoms of PD include tremors, especially in hands, arms, or legs, bradykinesia (slowness of movement), muscle rigidity, and shuffling gait. The disease is characterised primarily by motor symptoms like TRAP - tremors, rigidity, akinesia, and postural instability (difficulty to maintain balance). Non-motor symptoms such as depression and anxiety, sleep disturbances, cognitive impairment, constipation, and loss of smell (anosmia) are also seen in some patients. People ideally should watch out for are persistent hand tremors, stiffness or reduced arm swing on one side, slowness in daily activities, difficulty with balance or small handwriting, and soft or slurred speech, said Dr Sowmya M, senior consultant of Neurology at Aster RV Hospital, Bengaluru. 'The earliest signs are often so subtle that they go unnoticed or are mistaken for signs of aging or stress. Tremors are the hallmark symptom, typically starting on one side of the body, mostly in a hand or finger while at rest. Non-motor symptoms can appear years before motor symptoms begin. In such cases, people should always consult neurologists as symptoms like anxiety, loss of sense of smell, sleep disturbances, and even subtle cognitive decline are not always linked to Parkinson's by non-specialist physicians and it delays the diagnosis,' Dr Sowmya said. Clinical diagnosis Diagnosing Parkinson's is largely clinical as no blood test or scan can confirm it with certainty. A neurologist typically evaluates a combination of symptoms, medical history, and physical examinations. Imaging tools like MRI or CT scans are used to rule out other conditions, while a specialised nuclear imaging scan, known as DaTscan, can visualise dopamine activity in the brain. 'Diagnosis of Parkinson's disease is primarily based on signs and symptoms, typically motor-related, identified through neurological examination. Medical imaging techniques like positron emission tomography can support the diagnosis,' Dr Lulup Kumar Sahoo, professor in the Neuro Medicine department of IMS and SUM Hospital, Bhubaneswar said. Treatment begins with medications to increase dopamine levels. Patients generally respond well to dopamine supplementation, commonly known as Syndopa. Though many patients benefit from Syndopa, its effects tend to last for only a short period. Levodopa, often combined with Carbidopa, is also a commonly used drug. It helps replenish dopamine and improves muscle control, though its long-term use can lead to side effects such as dyskinesia. New hope Two major breakthroughs in Parkinson's treatment have emerged in recent years - magnetic resonance-guided focused ultrasound (MRgFUS) and deep brain stimulation (DBS). Focused ultrasound is a non-invasive technique that uses sound waves, guided by MRI, to target and destroy tiny areas of brain tissue responsible for tremors, without impacting surrounding healthy tissues. It does not require anaesthesia, surgery, or recovery time. 'A great alternative to traditional brain surgery, focused ultrasound can be beneficial for patients who haven't responded well to medication or prefer non-invasive procedures. Patients come in shaking and walk out with steady hands after the procedure. The treatment requires no surgical incisions or implants, and the mild transient numbness is resolved within days,' said Dr Sunil Patra, senior neurosurgeon at Manipal Hospitals, Bhubaneswar. Dr Sahoo said MRgFUS uses over 1,000 beams of focused ultrasound energy directed at a precise point in the brain, typically the thalamus, which is involved in motor control. Guided in real time by high-resolution MRI imaging, the treatment raises the temperature of the targeted tissue to a point where it is thermally ablated, disrupting the abnormal brain circuits causing tremors. 'The entire process is performed without scalpels, anaesthesia, or hospitalisation. Patients remain awake and responsive, allowing physicians to evaluate the effects in real time. Most patients experience immediate and significant reduction in tremor, immediately after the procedure. It, however, costs around `25 lakh, almost double the cost of DBS,' he added. DBS, on the other hand, involves implanting electrodes into specific brain regions such as the subthalamic nucleus or globus pallidus, guided by MRI. These electrodes deliver controlled electrical pulses that modulate abnormal brain activity. DBS can significantly reduce tremors, stiffness, and medication dependence. 'In DBS surgery or brain pacemaker surgery, small burrholes (keyhole) are made in the skull and electrodes are placed deep inside the brain under stereotactic guidance. These electrodes will be connected to a battery placed in the subcutaneous pouch in the upper chest. Based on the patient's symptomatic profile, the electrodes can be activated by switching on the battery with specified current. The electrodes will stimulate the desired neurons and give symptomatic relief,' Dr T P Jeyaselva Senthilkumar, senior consultant neurosurgeon, SRM Global Hospitals, Chennai. 'It is a one-day procedure and requires the patient to stay at the hospital for five days for observation and wound healing. The programming of the impulse generator battery will begin after two weeks, once the patient is stable. It is another one-day procedure,' added Dr Asha Kishore, director of the Parkinson's and Movement Disorders Centre at Aster Kerala Cluster. Senthilkumar added that to be eligible for DBS, the patient should have been responsive to oral medications. The total cost can range from Rs 15.5 lakh to Rs 20 lakh, based on model of implant used.
